Reports for NALOXONE
Ingredient
NALOXONE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-05-09 | 221534 |
TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Actual shortage | 2024-03-07 | 2024-05-16 | 221537 |
MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-22 | 2017-04-12 | 3922 |
MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-04-20 | 2019-09-18 | 7392 |
MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-03-16 | 2019-09-18 | 3089 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 |
Showing 1 to 2 of 2